カテゴリー： QYResearch, 世界

世界の二重バレル抗体薬市場 2019年

【英語タイトル】Global Double Barreled Antibodies Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X06729）・商品コード：DATA909X06729
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：110
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、二重バレル抗体薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、レモバブ、BLINCYTO、その他に、用途別には、肺がん、脳がん、肝臓がん、その他にセグメント区分し、二重バレル抗体薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・二重バレル抗体薬の世界市場概要
・二重バレル抗体薬の製造コスト構成分析
・二重バレル抗体薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・二重バレル抗体薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・二重バレル抗体薬のセグメント分析（種類別）
（レモバブ、BLINCYTO、その他）
・二重バレル抗体薬のセグメント分析（用途別）
（肺がん、脳がん、肝臓がん、その他）
・二重バレル抗体薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Amgen Inc.、F. Hoffman La Roche Ltd.、AbbVie Inc.、OncoMed Pharmaceuticals, Inc.、Glenmark Pharmaceuticals Limited、Xencor, Inc.、MacroGenics, Inc.、Aptevo Therapeutics Inc.、Ligand Pharmaceuticals, Inc.、Regeneron Pharmaceuticals, Inc.、Fresenius SE & Co. KGaA、Merus N.V.、）
・二重バレル抗体薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Double Barreled Antibodies Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Double Barreled Antibodies Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Double Barreled Antibodies Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Double Barreled Antibodies Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Double Barreled Antibodies Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Amgen Inc.
F. Hoffman La Roche Ltd.
AbbVie Inc.
OncoMed Pharmaceuticals, Inc.
Glenmark Pharmaceuticals Limited
Xencor, Inc.
MacroGenics, Inc.
Aptevo Therapeutics Inc.
Ligand Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Fresenius SE & Co. KGaA
Merus N.V.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Removab
BLINCYTO
Others

Segment by Application
Lung Cancer
Brain Cancer
Liver Cancer
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Double Barreled Antibodies Drug
1.1 Definition of Double Barreled Antibodies Drug
1.2 Double Barreled Antibodies Drug Segment by Type
1.2.1 Global Double Barreled Antibodies Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Removab
1.2.3 BLINCYTO
1.2.4 Others
1.3 Double Barreled Antibodies Drug Segment by Applications
1.3.1 Global Double Barreled Antibodies Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Lung Cancer
1.3.3 Brain Cancer
1.3.4 Liver Cancer
1.3.5 Others
1.4 Global Double Barreled Antibodies Drug Overall Market
1.4.1 Global Double Barreled Antibodies Drug Revenue (2014-2025)
1.4.2 Global Double Barreled Antibodies Drug Production (2014-2025)
1.4.3 North America Double Barreled Antibodies Drug Status and Prospect (2014-2025)
1.4.4 Europe Double Barreled Antibodies Drug Status and Prospect (2014-2025)
1.4.5 China Double Barreled Antibodies Drug Status and Prospect (2014-2025)
1.4.6 Japan Double Barreled Antibodies Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Double Barreled Antibodies Drug Status and Prospect (2014-2025)
1.4.8 India Double Barreled Antibodies Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Double Barreled Antibodies Drug
2.3 Manufacturing Process Analysis of Double Barreled Antibodies Drug
2.4 Industry Chain Structure of Double Barreled Antibodies Drug

3 Development and Manufacturing Plants Analysis of Double Barreled Antibodies Drug
3.1 Capacity and Commercial Production Date
3.2 Global Double Barreled Antibodies Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Double Barreled Antibodies Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Double Barreled Antibodies Drug Production and Capacity Analysis
4.2 Double Barreled Antibodies Drug Revenue Analysis
4.3 Double Barreled Antibodies Drug Price Analysis
4.4 Market Concentration Degree

5 Double Barreled Antibodies Drug Regional Market Analysis
5.1 Double Barreled Antibodies Drug Production by Regions
5.1.1 Global Double Barreled Antibodies Drug Production by Regions
5.1.2 Global Double Barreled Antibodies Drug Revenue by Regions
5.2 Double Barreled Antibodies Drug Consumption by Regions
5.3 North America Double Barreled Antibodies Drug Market Analysis
5.3.1 North America Double Barreled Antibodies Drug Production
5.3.2 North America Double Barreled Antibodies Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Double Barreled Antibodies Drug Import and Export
5.4 Europe Double Barreled Antibodies Drug Market Analysis
5.4.1 Europe Double Barreled Antibodies Drug Production
5.4.2 Europe Double Barreled Antibodies Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Double Barreled Antibodies Drug Import and Export
5.5 China Double Barreled Antibodies Drug Market Analysis
5.5.1 China Double Barreled Antibodies Drug Production
5.5.2 China Double Barreled Antibodies Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Double Barreled Antibodies Drug Import and Export
5.6 Japan Double Barreled Antibodies Drug Market Analysis
5.6.1 Japan Double Barreled Antibodies Drug Production
5.6.2 Japan Double Barreled Antibodies Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Double Barreled Antibodies Drug Import and Export
5.7 Southeast Asia Double Barreled Antibodies Drug Market Analysis
5.7.1 Southeast Asia Double Barreled Antibodies Drug Production
5.7.2 Southeast Asia Double Barreled Antibodies Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Double Barreled Antibodies Drug Import and Export
5.8 India Double Barreled Antibodies Drug Market Analysis
5.8.1 India Double Barreled Antibodies Drug Production
5.8.2 India Double Barreled Antibodies Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Double Barreled Antibodies Drug Import and Export

6 Double Barreled Antibodies Drug Segment Market Analysis (by Type)
6.1 Global Double Barreled Antibodies Drug Production by Type
6.2 Global Double Barreled Antibodies Drug Revenue by Type
6.3 Double Barreled Antibodies Drug Price by Type

7 Double Barreled Antibodies Drug Segment Market Analysis (by Application)
7.1 Global Double Barreled Antibodies Drug Consumption by Application
7.2 Global Double Barreled Antibodies Drug Consumption Market Share by Application (2014-2019)

8 Double Barreled Antibodies Drug Major Manufacturers Analysis
8.1 Amgen Inc.
8.1.1 Amgen Inc. Double Barreled Antibodies Drug Production Sites and Area Served
8.1.2 Amgen Inc. Product Introduction, Application and Specification
8.1.3 Amgen Inc. Double Barreled Antibodies Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 F. Hoffman La Roche Ltd.
8.2.1 F. Hoffman La Roche Ltd. Double Barreled Antibodies Drug Production Sites and Area Served
8.2.2 F. Hoffman La Roche Ltd. Product Introduction, Application and Specification
8.2.3 F. Hoffman La Roche Ltd. Double Barreled Antibodies Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 AbbVie Inc.
8.3.1 AbbVie Inc. Double Barreled Antibodies Drug Production Sites and Area Served
8.3.2 AbbVie Inc. Product Introduction, Application and Specification
8.3.3 AbbVie Inc. Double Barreled Antibodies Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 OncoMed Pharmaceuticals, Inc.
8.4.1 OncoMed Pharmaceuticals, Inc. Double Barreled Antibodies Drug Production Sites and Area Served
8.4.2 OncoMed Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.4.3 OncoMed Pharmaceuticals, Inc. Double Barreled Antibodies Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Glenmark Pharmaceuticals Limited
8.5.1 Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Production Sites and Area Served
8.5.2 Glenmark Pharmaceuticals Limited Product Introduction, Application and Specification
8.5.3 Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Xencor, Inc.
8.6.1 Xencor, Inc. Double Barreled Antibodies Drug Production Sites and Area Served
8.6.2 Xencor, Inc. Product Introduction, Application and Specification
8.6.3 Xencor, Inc. Double Barreled Antibodies Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 MacroGenics, Inc.
8.7.1 MacroGenics, Inc. Double Barreled Antibodies Drug Production Sites and Area Served
8.7.2 MacroGenics, Inc. Product Introduction, Application and Specification
8.7.3 MacroGenics, Inc. Double Barreled Antibodies Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Aptevo Therapeutics Inc.
8.8.1 Aptevo Therapeutics Inc. Double Barreled Antibodies Drug Production Sites and Area Served
8.8.2 Aptevo Therapeutics Inc. Product Introduction, Application and Specification
8.8.3 Aptevo Therapeutics Inc. Double Barreled Antibodies Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Ligand Pharmaceuticals, Inc.
8.9.1 Ligand Pharmaceuticals, Inc. Double Barreled Antibodies Drug Production Sites and Area Served
8.9.2 Ligand Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.9.3 Ligand Pharmaceuticals, Inc. Double Barreled Antibodies Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Regeneron Pharmaceuticals, Inc.
8.10.1 Regeneron Pharmaceuticals, Inc. Double Barreled Antibodies Drug Production Sites and Area Served
8.10.2 Regeneron Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.10.3 Regeneron Pharmaceuticals, Inc. Double Barreled Antibodies Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Fresenius SE & Co. KGaA
8.12 Merus N.V.

9 Development Trend of Analysis of Double Barreled Antibodies Drug Market
9.1 Global Double Barreled Antibodies Drug Market Trend Analysis
9.1.1 Global Double Barreled Antibodies Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Double Barreled Antibodies Drug Regional Market Trend
9.2.1 North America Double Barreled Antibodies Drug Forecast 2019-2025
9.2.2 Europe Double Barreled Antibodies Drug Forecast 2019-2025
9.2.3 China Double Barreled Antibodies Drug Forecast 2019-2025
9.2.4 Japan Double Barreled Antibodies Drug Forecast 2019-2025
9.2.5 Southeast Asia Double Barreled Antibodies Drug Forecast 2019-2025
9.2.6 India Double Barreled Antibodies Drug Forecast 2019-2025
9.3 Double Barreled Antibodies Drug Market Trend (Product Type)
9.4 Double Barreled Antibodies Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Double Barreled Antibodies Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Double Barreled Antibodies Drug
Table Global Double Barreled Antibodies Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Double Barreled Antibodies Drug Production Market Share by Types in 2018
Figure Removab Product Picture
Figure BLINCYTO Product Picture
Figure Others Product Picture
Table Global Double Barreled Antibodies Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Double Barreled Antibodies Drug Consumption Market Share by Applications in 2018
Figure Lung Cancer
Figure Brain Cancer
Figure Liver Cancer
Figure Others
Figure Global Double Barreled Antibodies Drug Revenue (Million USD) (2014-2025)
Figure Global Double Barreled Antibodies Drug Production (K Pcs) (2014-2025)
Figure North America Double Barreled Antibodies Drug Market Size (Million USD) (2014-2025)
Figure Europe Double Barreled Antibodies Drug Market Size (Million USD) (2014-2025)
Figure China Double Barreled Antibodies Drug Market Size (Million USD) (2014-2025)
Figure Japan Double Barreled Antibodies Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Double Barreled Antibodies Drug Market Size (Million USD) (2014-2025)
Figure India Double Barreled Antibodies Drug Market Size (Million USD) (2014-2025)
Table Double Barreled Antibodies Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Double Barreled Antibodies Drug in 2018
Figure Manufacturing Process Analysis of Double Barreled Antibodies Drug
Figure Industry Chain Structure of Double Barreled Antibodies Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Double Barreled Antibodies Drug Manufacturing Plants Distribution
Table Double Barreled Antibodies Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Double Barreled Antibodies Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Double Barreled Antibodies Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Double Barreled Antibodies Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Double Barreled Antibodies Drug Production Share by Manufacturers in 2018
Table Double Barreled Antibodies Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Double Barreled Antibodies Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Double Barreled Antibodies Drug Revenue Share by Manufacturers in 2018
Table Double Barreled Antibodies Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Double Barreled Antibodies Drug Production by Regions 2014-2019 (K Pcs)
Table Global Double Barreled Antibodies Drug Production Market Share by Regions 2014-2019
Figure Global Double Barreled Antibodies Drug Production Market Share by Regions in 2018
Table Global Double Barreled Antibodies Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Double Barreled Antibodies Drug Revenue Market Share by Regions 2014-2019
Figure Global Double Barreled Antibodies Drug Revenue Market Share by Regions in 2018
Table Global Double Barreled Antibodies Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Double Barreled Antibodies Drug Consumption Market Share by Regions 2014-2019
Figure North America Double Barreled Antibodies Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Double Barreled Antibodies Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Double Barreled Antibodies Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Double Barreled Antibodies Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Double Barreled Antibodies Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Double Barreled Antibodies Drug Production, Consumption Import and Export (K Pcs)
Figure China Double Barreled Antibodies Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Double Barreled Antibodies Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Double Barreled Antibodies Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Double Barreled Antibodies Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Double Barreled Antibodies Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Double Barreled Antibodies Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Double Barreled Antibodies Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Double Barreled Antibodies Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Double Barreled Antibodies Drug Production, Consumption Import and Export (K Pcs)
Figure India Double Barreled Antibodies Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Double Barreled Antibodies Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Double Barreled Antibodies Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Double Barreled Antibodies Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Double Barreled Antibodies Drug Market Share by Application (2014-2019)
Table Amgen Inc. Double Barreled Antibodies Drug Production Sites and Area Served
Table Amgen Inc. Double Barreled Antibodies Drug Product Introduction, Application and Specification
Table Amgen Inc. Double Barreled Antibodies Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Amgen Inc. Double Barreled Antibodies Drug Production Growth Rate (2014-2019)
Table Amgen Inc. Double Barreled Antibodies Drug Production Market Share (2014-2019)
Figure Amgen Inc. Double Barreled Antibodies Drug Revenue Market Share (2014-2019)
Table Amgen Inc. Double Barreled Antibodies Drug Main Business and Markets Served
Table F. Hoffman La Roche Ltd. Double Barreled Antibodies Drug Production Sites and Area Served
Table F. Hoffman La Roche Ltd. Double Barreled Antibodies Drug Product Introduction, Application and Specification
Table F. Hoffman La Roche Ltd. Double Barreled Antibodies Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table F. Hoffman La Roche Ltd. Double Barreled Antibodies Drug Production Growth Rate (2014-2019)
Table F. Hoffman La Roche Ltd. Double Barreled Antibodies Drug Production Market Share (2014-2019)
Figure F. Hoffman La Roche Ltd. Double Barreled Antibodies Drug Revenue Market Share (2014-2019)
Table F. Hoffman La Roche Ltd. Double Barreled Antibodies Drug Main Business and Markets Served
Table AbbVie Inc. Double Barreled Antibodies Drug Production Sites and Area Served
Table AbbVie Inc. Double Barreled Antibodies Drug Product Introduction, Application and Specification
Table AbbVie Inc. Double Barreled Antibodies Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AbbVie Inc. Double Barreled Antibodies Drug Production Growth Rate (2014-2019)
Table AbbVie Inc. Double Barreled Antibodies Drug Production Market Share (2014-2019)
Figure AbbVie Inc. Double Barreled Antibodies Drug Revenue Market Share (2014-2019)
Table AbbVie Inc. Double Barreled Antibodies Drug Main Business and Markets Served
Table OncoMed Pharmaceuticals, Inc. Double Barreled Antibodies Drug Production Sites and Area Served
Table OncoMed Pharmaceuticals, Inc. Double Barreled Antibodies Drug Product Introduction, Application and Specification
Table OncoMed Pharmaceuticals, Inc. Double Barreled Antibodies Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table OncoMed Pharmaceuticals, Inc. Double Barreled Antibodies Drug Production Growth Rate (2014-2019)
Table OncoMed Pharmaceuticals, Inc. Double Barreled Antibodies Drug Production Market Share (2014-2019)
Figure OncoMed Pharmaceuticals, Inc. Double Barreled Antibodies Drug Revenue Market Share (2014-2019)
Table OncoMed Pharmaceuticals, Inc. Double Barreled Antibodies Drug Main Business and Markets Served
Table Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Production Sites and Area Served
Table Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Product Introduction, Application and Specification
Table Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Production Growth Rate (2014-2019)
Table Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Production Market Share (2014-2019)
Figure Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Revenue Market Share (2014-2019)
Table Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Main Business and Markets Served
Table Xencor, Inc. Double Barreled Antibodies Drug Production Sites and Area Served
Table Xencor, Inc. Double Barreled Antibodies Drug Product Introduction, Application and Specification
Table Xencor, Inc. Double Barreled Antibodies Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Xencor, Inc. Double Barreled Antibodies Drug Production Growth Rate (2014-2019)
Table Xencor, Inc. Double Barreled Antibodies Drug Production Market Share (2014-2019)
Figure Xencor, Inc. Double Barreled Antibodies Drug Revenue Market Share (2014-2019)
Table Xencor, Inc. Double Barreled Antibodies Drug Main Business and Markets Served
Table MacroGenics, Inc. Double Barreled Antibodies Drug Production Sites and Area Served
Table MacroGenics, Inc. Double Barreled Antibodies Drug Product Introduction, Application and Specification
Table MacroGenics, Inc. Double Barreled Antibodies Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table MacroGenics, Inc. Double Barreled Antibodies Drug Production Growth Rate (2014-2019)
Table MacroGenics, Inc. Double Barreled Antibodies Drug Production Market Share (2014-2019)
Figure MacroGenics, Inc. Double Barreled Antibodies Drug Revenue Market Share (2014-2019)
Table MacroGenics, Inc. Double Barreled Antibodies Drug Main Business and Markets Served
Table Aptevo Therapeutics Inc. Double Barreled Antibodies Drug Production Sites and Area Served
Table Aptevo Therapeutics Inc. Double Barreled Antibodies Drug Product Introduction, Application and Specification
Table Aptevo Therapeutics Inc. Double Barreled Antibodies Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Aptevo Therapeutics Inc. Double Barreled Antibodies Drug Production Growth Rate (2014-2019)
Table Aptevo Therapeutics Inc. Double Barreled Antibodies Drug Production Market Share (2014-2019)
Figure Aptevo Therapeutics Inc. Double Barreled Antibodies Drug Revenue Market Share (2014-2019)
Table Aptevo Therapeutics Inc. Double Barreled Antibodies Drug Main Business and Markets Served
Table Ligand Pharmaceuticals, Inc. Double Barreled Antibodies Drug Production Sites and Area Served
Table Ligand Pharmaceuticals, Inc. Double Barreled Antibodies Drug Product Introduction, Application and Specification
Table Ligand Pharmaceuticals, Inc. Double Barreled Antibodies Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ligand Pharmaceuticals, Inc. Double Barreled Antibodies Drug Production Growth Rate (2014-2019)
Table Ligand Pharmaceuticals, Inc. Double Barreled Antibodies Drug Production Market Share (2014-2019)
Figure Ligand Pharmaceuticals, Inc. Double Barreled Antibodies Drug Revenue Market Share (2014-2019)
Table Ligand Pharmaceuticals, Inc. Double Barreled Antibodies Drug Main Business and Markets Served
Table Regeneron Pharmaceuticals, Inc. Double Barreled Antibodies Drug Production Sites and Area Served
Table Regeneron Pharmaceuticals, Inc. Double Barreled Antibodies Drug Product Introduction, Application and Specification
Table Regeneron Pharmaceuticals, Inc. Double Barreled Antibodies Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Regeneron Pharmaceuticals, Inc. Double Barreled Antibodies Drug Production Growth Rate (2014-2019)
Table Regeneron Pharmaceuticals, Inc. Double Barreled Antibodies Drug Production Market Share (2014-2019)
Figure Regeneron Pharmaceuticals, Inc. Double Barreled Antibodies Drug Revenue Market Share (2014-2019)
Table Regeneron Pharmaceuticals, Inc. Double Barreled Antibodies Drug Main Business and Markets Served
Table Fresenius SE & Co. KGaA Double Barreled Antibodies Drug Production Sites and Area Served
Table Merus N.V. Double Barreled Antibodies Drug Production Sites and Area Served
Figure Global Double Barreled Antibodies Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Double Barreled Antibodies Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Double Barreled Antibodies Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Double Barreled Antibodies Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Double Barreled Antibodies Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Double Barreled Antibodies Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Double Barreled Antibodies Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Double Barreled Antibodies Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Double Barreled Antibodies Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Double Barreled Antibodies Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Double Barreled Antibodies Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Double Barreled Antibodies Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Double Barreled Antibodies Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Double Barreled Antibodies Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Double Barreled Antibodies Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Double Barreled Antibodies Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Double Barreled Antibodies Drug by Application (2019-2025)
Table Double Barreled Antibodies Drug Distributors List
Table Double Barreled Antibodies Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Amgen Inc.、F. Hoffman La Roche Ltd.、AbbVie Inc.、OncoMed Pharmaceuticals, Inc.、Glenmark Pharmaceuticals Limited、Xencor, Inc.、MacroGenics, Inc.、Aptevo Therapeutics Inc.、Ligand Pharmaceuticals, Inc.、Regeneron Pharmaceuticals, Inc.、Fresenius SE & Co. KGaA、Merus N.V.、

★調査レポート[世界の二重バレル抗体薬市場 2019年] (コード：DATA909X06729)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の二重バレル抗体薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のコクシジオイデス症薬剤市場 2019年
    DATA909X05597 / QYResearch / 2019年11月15日 / ※本調査レポートは、コクシジオイデス症薬剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他に、用途別には、クリニック、病院、その他にセグメント区分し、コクシジオイデス症薬剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・コクシジオイデス症薬剤の世界市場概要 ・コクシジオイデス症薬剤の製造コスト構成分析 ・コクシジオイデス症薬剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・コクシジオイデス症薬剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・コクシジオイデス症薬剤のセグメント分析（種類別） （VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他）...The global Coccidioidomycosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Coccidioidomycosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Coccidioidomycosis Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Coccidioidomycosis Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Coccidioidomycosis Drug manufacturing...
  • 世界の一次抗体市場 2019年
    DATA909X13721 / QYResearch / 2019年11月20日 / ※本調査レポートは、一次抗体の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、人間、動物に、用途別には、ELISA、ウェスタンブロット、免疫染色、免疫組織化学、免疫細胞化学、その他にセグメント区分し、一次抗体の世界市場を分析しました。 ・エグゼクティブ・サマリー ・一次抗体の世界市場概要 ・一次抗体の製造コスト構成分析 ・一次抗体の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・一次抗体の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・一次抗体のセグメント分析（種類別） （人間、動物）...The global Primary Antibodies market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Primary Antibodies volume and value at global level, regional level and company level. From a global perspective, this report represents overall Primary Antibodies market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Primary Antibodies in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Primary Antibodies manufacturing...
  • 世界の視神経症薬市場 2019年
    DATA909X12314 / QYResearch / 2019年11月20日 / ※本調査レポートは、視神経症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BA-240、IWP-953、LM-22A4、その他に、用途別には、クリニック、病院、在宅ケアにセグメント区分し、視神経症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・視神経症薬の世界市場概要 ・視神経症薬の製造コスト構成分析 ・視神経症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・視神経症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・視神経症薬のセグメント分析（種類別） （BA-240、IWP-953、LM-22A4、その他）...The global Optic Neuropathy Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Optic Neuropathy Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Optic Neuropathy Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Optic Neuropathy Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の研究用抗体および試薬市場 2019年
    DATA909X14282 / QYResearch / 2019年11月20日 / ※本調査レポートは、研究用抗体および試薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、酵素免疫測定法、ポリメラーゼ連鎖反応、ウェスタンブロッティング、フローサイトメトリー、免疫蛍光、免疫沈降、その他に、用途別には、製薬・バイオテクノロジー企業、学術研究機関、受託研究機関、その他にセグメント区分し、研究用抗体および試薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・研究用抗体および試薬の世界市場概要 ・研究用抗体および試薬の製造コスト構成分析 ・研究用抗体および試薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・研究用抗体および試薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・研究用抗体および試薬のセグメント分析（種類別） （酵素免疫測定法、ポリメラーゼ連鎖反応、ウェスタンブロッティング、フローサイトメトリー、免疫蛍光、免疫沈降、その他）...The global Research Antibodies and Reagents market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Research Antibodies and Reagents volume and value at global level, regional level and company level. From a global perspective, this report represents overall Research Antibodies and Reagents market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Research Antibodies and Reagents in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

    • ◆H&Iグローバルリサーチのお客様（例）◆